Company Filing History:
Years Active: 1976-1988
Title: The Innovative Contributions of Paule A. Gattel
Introduction
Paule A. Gattel is a notable inventor based in Caluire, France, recognized for her innovative contributions in the field of protein purification. With a portfolio of three patents, Gattel has made significant advancements that aid in the processing of blood-derived proteins, showcasing her expertise and commitment to scientific progress.
Latest Patents
Gattel's latest patents include groundbreaking processes aimed at preparing essential proteins from hemolyzed blood. One patent describes a method for preparing principal proteins which involves clarifying hemolyzed blood at a pH of 4 to 6 in the presence of less than 15% alcohol. This is followed by a concentration step and subsequent anion exchange chromatography to separate hemoglobin while eluting the albumin. Another patent focuses on the preparation of purified albumin from frozen placenta and hemolyzed blood, detailing steps for eliminating hemoglobin and enzymes to achieve a high-quality product.
Career Highlights
Paule A. Gattel currently works at Institut Merieux, a well-regarded company known for its contributions to the medical and biopharmaceutical fields. Her innovative inventions not only contribute to the scientific community but also hold potential therapeutic applications, underscoring her impact in the industry.
Collaborations
Throughout her career, Gattel has collaborated closely with esteemed colleagues such as Robert A. Plan and Jacques C. Liautaud. These partnerships have fostered a collaborative environment that enhances innovation and leads to impactful scientific discoveries.
Conclusion
Paule A. Gattel exemplifies the spirit of innovation within the field of protein purification. Her contributions through patented processes not only advance scientific methods but also pave the way for future developments in medical and biopharmaceutical applications. As she continues her work at Institut Merieux, her impact on science and medicine is poised to grow even further.